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During the catalytic reactions of flavoprotein hydroxylases and bacterial luciferase, flavin per- 
oxides are formed as intermediates [see Massey, V. and Hemmerich, P. (1976) in The Enzymes, 
3rd edn (P. Boyer, ed.) pp. 421 - 505, Academic Press, New York]. These intermediates have been 
postulated to be C(4a) derivatives of the flavin coenzyme. To test this hypothesis, modified flavin 
coenzymes carrying an oxygen substituent at position C (4a) of the isoalloxazine ring were synthesized. 
They are tightly bound by the apoenzymes of D-amino acid oxidase, p-hydroxybenzoate hydroxylase 
and lactate oxidase ; the resulting complexes show spectral properties closely similar to those of the 
transient oxygen adducts of the hydroxylases. The optical spectra of the lumiflavin model compounds 
were found to be highly dependent on the solvent environment and nature of the substituents. Under 
appropriate conditions they simulate satisfactorily the spectra of the transient enzymatic oxygen 
adducts. The results support the proposal that the primary oxygen adducts formed with these flavo- 
proteins on reaction of the reduced enzymes with oxygen are flavin C(4a) peroxides. 
Flavoprotein oxidases and monooxygenases are 
redox enzymes which catalyze the reaction of molec- 
ular oxygen with a variety of substrates [l - 31. Char- 
acteristic of this catalysis is the reaction with oxygen 
of the reduced flavoenzyme in the presence of substrate 
or product. It is the reduced flavin which is involved 
in the activation of oxygen. With monooxygenases the 
result is the incorporation of one atom of the molecule 
of oxygen in the substrate, and the reduction of the 
other one to water. First insights into the mechanism 
of the rapid reaction of reduced flavin with 0 2  [4,5] 
were obtained from its kinetics, which indicated the 
reversible formation of a Flred-02 complex prior to 
the actual electron transfer [6,7]. Direct spectral 
evidence for the transient occurrence of a covalent 
flavin-oxygen adduct was obtained later in studies 
with the enzymes meliotate hydroxylase [8], p-hydro- 
xybenzoate hydroxylase [9], phenol hydroxylase [2] 
and very recently with salicylate hydroxylase [ 101. 
In the case of p-hydroxybenzoate hydroxylase a 
detailed kinetic investigation lead to the discovery of 
at least three sequential intermediates arising from 
the reaction of the reduced enzyme with oxygen [ l l ]  
Abbreviations. NMR, Nuclear magnetic resonance; 4a-OH- 
FAD and 4a-OH-FMN for 5-ethyl-4a-hydroxy-4a,S-dihydro-FAD 
and the corresponding FMN derivative. 
Enzymes. D-Amino acid oxidase (EC 1.4.3.3); p-hydroxy- 
benzoate hydroxylase (EC 1.14.13.2); lactate oxidase (EC 1.13.12.4); 
phenol hydroxylase (EC 1.14.13.7); melilotate hydroxylase (EC 1.14. 
13.4). 
during the process of hydroxylation of a substrate. 
Comparison of the characteristic spectra of two of 
the three intermediates [ l l ]  with those of models 
[12,13] suggested the structure of covalent flavin 
adducts at C(4a), C(4a)-OOH and C(4a)-OH. 
The possible structure and function of flavin 
oxygen intermediates, however, has been a matter 
of some controversy, and most flavin functions, e.g. 
positions C(4a), N(5), C(6), C(8), C(9a) and C(lOa), 
have been proposed as the position of a covalent link 
to a catalytically active oxygen peroxide [1,2,4,5, 
14- 191, but as yet none of these structures has been 
verified in biological systems. 
The aim of the present work was the structure 
elucidation of the enzymatic F1-02 intermediates 
mentioned above by comparison of their spectral 
properties with those of suitable, enzyme-bound 
modified coenzymes of unambiguous structure. Deri- 
vatives of the 4a,5-dihydro-isoalloxazine at the FAD 
and FMN level, which carry an oxygen function at 
C(4a), were first chosen as models as their spectra 
[13,20] bear considerable similarity to those of the 
transient intermediates [l 11. The chromophores which 
can be derived from other isomeric forms of the reduc- 
ed flavin have spectra with considerably different 
properties [21]. 4a-OR flavins are accessible only 
upon blocking of N (5) of the isoalloxazine through 
alkylation [12]. A 4a-OH substituent rather than a 
4 a-OOH substituent was chosen because the two 
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intermediates with the proposed structures of - OOH, 
and -OH flavin adducts have almost identical 
spectra [ll],  and because a rapid exchange of an 
-0OH substituent by -OH arising from aqueous 
solvent has been shown to occur [20]. 
EXPERIMENTAL PROCEDURE 
Spectroscopic Methods 
Absorption spectra were recorded with a Cary 
model 17 or 118 spectrophotometer. Fluorescence 
emission and excitation spectra were recorded at the 
temperature indicated with a ratio-recording fluori- 
meter, which will be described elsewhere (Ballou, 
D. P. and Ford, G., unpublished), the fluorescence 
excitation spectra are thus corrected for shape and 
A n a x .  
The rapid reaction experiments were carried out 
with a Gibson-Milnes stopped-flow spectrophotom- 
eter, also equipped for fluorescence observation. 
Enzymes, Apoenzymes and Materials 
Alkaline phosphatase from E. coli was obtained 
from Worthington. Naja naja venom (phosphodi- 
esterase) was obtained from the Ross Allen Reptile 
Institute (Silver Spring, Florida). FAD and FMN were 
from Sigma Chemical Co. and were used without 
further purification for the chemical syntheses. The 
other chemical compounds used were from commercial 
sources and were usually purified by recrystallization. 
5-Ethyl-flavoquinonium perchlorate was synthesized 
as described elsewhere [12]. 
The following enzymes and apoenzymes were 
prepared by published procedures : flavodoxin was 
from Peptostreptococcus elsdenii [22] and apoflavo- 
doxin [23], D-amino acid oxidase from pig kidney [24] 
and apo D-amino acid oxidase [25], lactate oxidase 
from Mycobacterium smegntatis [26] and apo lactate 
oxidase [27], melilotate hydroxylase [28], and apo- 
melilotate hydroxylase [25] ; p-hydroxy-benzoate hy- 
droxylase from Pseudomonas~uorescens was prepared 
by the procedure of Howell et al. [29], as modified by 
Entsch et al. [l l] .  Phenol hydroxylase from Tricho- 
sporon cutaneum [30] was a generous gift from Dr 
H. Neujahr; the apoenzyme [31] was prepared by 
dialysis against KBr by the procedure described [25]. 
Apo-p-hydroxybenzoate hydroxylase, as used in 
the experiments reported in this paper, was prepared 
by the following dialysis technique. A solution of 
25 - 30 pM enzyme was dialysed at 2 - 4 "C against 
50 vol. of a solution of 1 M KBr, 1 M urea, 0.5 mM 
EDTA, 0.3 mM p-hydroxybenzoate, and 0.1 M po- 
tassium phosphate, pH 7.9 to 8.0. The dialysis fluid 
was changed every 12 h until the enzyme activity of 
the apoprotein solution was 2 %  or less of the total 
active enzyme present after reconstitution with FAD. 
The apoprotein solution then was dialysed with three 
changes against a solution of 0.3 M p-hydroxybenz- 
oate, 0.5 mM EDTA, and 0.1 M potassium phosphate, 
pH 7.5. A recovery of 70- 90 % of the starting enzyme 
activity was achieved. The apoprotein solution lost 
5 %  or less re-constitutable activity after 4 weeks at 
0 "C. The solution could be conveniently concentrated 
with a semipermeable membrane (e. g. Amincon Diaflo 
membrane PM-30). 
Chemical Syntheses 
5- Ethyl-4a-hydroxy-4a,5-dihydro- FAD (4a- OH- 
FAD). Solid FAD (50 mg) was dissolved in 5 ml of 
2.0 M potassium phosphate (a molar ratio of 9/l for 
dibasic/monobasic phosphate) and 5 ml of dimethyl- 
formamide was added. The mixture was stirred vigor- 
ously under nitrogen and 200 mg of sodium dithionite 
was added. The solution changed to a pale orange- 
yellow when reduction of the mixture was complete. 
1 g of ethyl iodide was added, the reaction mixture 
was stirred, and held at 10- 12 "C.  The alkylation of 
FAD was usually complete in 3 h. A subsequent 
addition of 0.5 g ethyl iodide was necessary after 80- 
90 min if the reaction was run under a stream of 
nitrogen. The reaction was followed spectrophoto- 
metrically. An aliquot of the upper (aqueous) layer 
was added to 1 M acetic acid and shaken quickly. The 
unchanged, oxidized FAD was measured by the ab- 
sorbance at 450 nm (E = 11.3 mM-' cm-'). The 
degree of alkylation was also determined on the same 
aliquot as follows. The pH was raised to 5.5 by adding 
5 M NaOH and the solution shaken again. The ab- 
sorption at 585 nm was followed to maximum forma- 
tion of the blue colour characteristic of the neutral 
radical of 5-ethyl-FAD (e = 4.0 mM-l cm-'). The 
synthesis was stopped when oxidized flavin was less 
than 5 %  of the total. The aqueous phase of the 
reaction mixture was adjusted at room temperature 
to pH 5.0 with 5 M phosphoric acid. Much of the 
phosphate present precipitated and was separated 
mechanically. The yellow solution was extracted 
three times with 50 ml of chloroform and once with 
50 ml of ether. The aqueous phase turned black due 
to the blue radical formed by oxidation with oxygen. 
Without delay, the pH was adjusted (if necessary) to 
4.9-5.0 with acetic acid or NaOH, and the solution 
cooled to 0 "C. 80- 100 pmol of NaN02 (in solution) 
was added to the product, which was then kept for 
10 min at 0 "C. The solution turned dark orange-red 
upon oxidation of the radical form. At 2-4 "C this 
solution ( 5  - 7 ml) was passed through a column of 
Bio-Gel P-2 (200 - 400 mesh in a column of 2.6 x 40cm, 
equilibrated with 50 mM potassium acetate, pH 4.9). 
The desired product separated from an orange-brown 
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band on the column, and was recognized by its char- 
acteristic absorption spectrum (Fig. 2). Smjll amounts 
of the blue radical form were frequently eluted with 
the product as detected by long-wavelength absorbance 
at pH 6.0-7.0. The radical present was conveniently 
oxidized before use by titration with a solution of 
potassium ferricyanide at 0 "C and pH 7.0. The band 
of product was followed on the column by unchanged 
FAD, which was recognized by its absorption at 
450 nm and by its green fluorescence; the product was 
not fluorescent. The peak fractions of highest purity 
(at least 95 % having the 4a-hydroxy-5-ethyl-isoal- 
loxazine structure) were collected and stored for use 
at - 70 "C. The product was stable at this temperature 
for at least 3 months. Aliquots could be kept at 0 "C 
for several hours (pH 5.0) with negligible decomposi- 
tion. The yield was approximately 30 % of the starting 
FAD on a molar basis. 
5-  Ethyl-4a- hydroxy -4aJ-dihydro - FMN (4a-OH- 
F M N )  was prepared from purified 4a-OH-FAD by 
incubation of the latter with phosphodiesterase (Naja 
naja venom) and separation over a Bio-Gel P-2 
column equilibrated with 0.5 M sodium acetate buffer 
pH 5.0. The corresponding 4a-OH-riboflavin may be 
prepared in a similar fashion by incubation with 
phosphatase. 
4a-OH-flavins at the FAD, FMN and riboflavin 
level are well separated by thin-layer chromatography 
on silica gel plates in butanol/acetic acid/water 
(12/3/5). The spots can be visualized by conversion to 
the red cations by spraying with 1 M HCl. 
5,8- 10, l l -  Tetramethyl-l,2dihydro-8H-benz[g]- 
oxazolo [2,3-e]-pteridin-4,6-dione, (4a,5-oxapropano- 
4a,5-dihydro-3-methyllumiflavin L$ structure insert 
in Fig.l), was synthesized as will be published else- 
where [32 a], m. p. 202 - 204 "C. The structure is con- 
firmed by X-ray crystallography [32]. 
RESULTS 
Synthesis and Chemical Properties ofwFlavin Models 
The synthesis of some 4a,5-dihydroflavins at the 
lumiflavin level as reported earlier [12], involves 
drastic reaction conditions (pH > 12), which would 
decompose FAD, or requires organic solvents, in 
which FAD or FMN are not soluble. These difficulties 
have been circumvented by the use of a biphasic 
solvent mixture (dimethylformamide/water) strongly 
buffered at pH 8, where the reduced isoalloxazine is 
monoionized; N(1)-H, pK 6.5. Under these conditions 
reduced FAD was found to be alkylated practically 
selectively at N (9, the other nucleophilic functions 
(e. g .  adenine) remaining unaltered, as indicated by 
the binding studies with apoenzyme detailed below. 
FAD analogues, in which the adenine moiety is 
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Fig. 1 .  Effect of C ( 4 a )  substituent andof solvent on the 4aJ-dihydro- 
flavin chrornophore. A solution of the 4a,5-bridged, lumiflavin model 
compound (see inserted structure), 4.0 mM in absolute dioxane 
was diluted with 99 vol. cyclohexane (-----), or 99 vol. 1.0 M 
NaCl solution (-). The flavin 4a-OH adduct (-.-.-.) (see 
inserted structure, R = H) is formed by addition of 10 pl of a 
10 mM potassium carbonate solution to 1.0 ml of a solution of 
5-ethyl-lumiflavinium perchlorate, 50 pM in absolute acetonitrile. 
The base is required for the neutralisation of C104. The 4a-00H 
adduct (. . . . . . )  (R = OH) is formed analogously by addition of 
10 pl of 85 % HzOz containing 10 mM potassium carbonate. Kemal 
and Bruice I201 have reported a similar spectrum of 5-methyl-4a- 
peroxy-lumiflavin in methanol 
modified, bind only very weakly to the apo enzyme of 
D-amino acid oxidase [33 - 351. The purity of the modi- 
fied OH-FAD is best estimated from the degree of 
conversion of the neutral species into the alloxazinium 
cation (Fig.2) [12], e.g. the ratios of the absorbancies 
at 257 and 357 nm (pH 7), versus 437 or 550 nm, at 
low pH and from the ratios of the cation absorbancies 
at 550 and 320 nm (= 3.2) for the cation. The purity 
was also checked by thin-layer chromatography in the 
system already described, where 4a-OH-FAD runs 
as a single spot, well separated from the FMN and 
riboflavin forms and from decomposition products. 
The 4a-OH-isoalloxazine structure was confirmed by 
its behavior towards reductants which is analogous 
to that reported for lumiflavine models [12,36]. 
The reversible removal of a solvent molecule from 
position C (4a) of 4a-OH-FAD and 4a-OH-FMN 
occurs with a pK 3.7. This pK compares with a pK 
of 4.1 for the corresponding lumiflavin derivative [12]. 
The corresponding pK for the C(4a), N(5)-oxa- 
propano-bridged lumiflavin model compound (cf. 
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Fig.2. Absorption spectrum of4a-OH-FAD,free in solution, and bound to apo D-amino acid oxidase, and release of the modified coenzyme from 
the holoenzyme. Curve ( '  . . . . .) shows the spectrum of 4a-OH-FAD 16.7 pM in 0.1 M phosphate buffer, pH 6.5. A solution of apoenzyme 
(0.30 ml of 0.21 mM) was added to a solution containing 10 equiv. of 4a-OH-FAD, to give 1.5 ml of 40 mM potassium acetate, 0.10 M po- 
tassium phosphate, and 0.4 mM EDTA, pH 7.1 at 0 "C. The solution was incubated at 25 "C for 6 min, cooled to 0 "C, and passed through a 
column of Sephadex G-25, equilibrated at 2-4 "C with 50 mM potassium phosphate and 0.4 mM EDTA, pH 7.5. Curve (-----), absorption 
spectrum of the eluted protein fraction. 1 .O ml of this solution was acidified with 80 p1 5 MHC1, incubated at 25 "C for 4 min and the protein 
precipitate centrifuged at 4 "C. Curve (-) represents the spectrum of the supernatant solution. The spectrum of the same solution after 
neutralization with 80 p1.5 M NaOH and addition of ferricyanide (5 pM final), and subtraction of the ferrycyanide absorption contribution, is 
closely similar to curve (. . . . .) 
structure, Fig.1) is lowered to 1.25, and reflects 
reversible addition of the terminal hydroxyl to posi- 
tion C(4a). 
Absorption Spectra of 4a-OR-5-R-4a,S-dihydrojlavins 
The spectra of 4a,5-dihydroflavins are characteriz- 
ed by the presence of two or three bands of strongly 
varying intensity at A > 270 nm (Fig. 1) and by a 
lowest energy transition with A, ranging from 327 
to 386 nm [12,13]. 
Thus any structural interpretation based on spec- 
tral comparisons with 4a,5-dihydroflavin models will 
be inherently ambiguous, unless the factors affecting 
the chromophore such as solvent, substituents, geo- 
metry, and also the internal mobility of the molecule 
have been deliniated. Such effects are well illustrated 
on Fig. 1. The 4aJ-bridged 4a,5-dihydro-flavin was 
chosen as a model, as it should be largely rigid as 
compared to other dihydroflavins, and thus simulate 
a restrained mobility possibly induced by enzyme 
active sites. In fact it approximates, in apolar medium, 
the spectral shape of the enzymatic intermediates [ll].  
X-ray crystallography shows that the benzene, pyr- 
azine and pyrimidine subnuclei form an only slightly 
distorted plane, whereby the plane formed by the 
-CH2-CH2-O- bridge is close to being per- 
pendicular to it [32]. Major spectral effects are observ- 
ed on variation of the C(4a) substituent, e.g. - N- Rz, 
-0 -R ,  -0-CO-R, -CH2-R.(R = alkylorH). 
The three absorption bands at A > 270 nm vary in their 
intensity by a factor up to two, in some cases the 'sec- 
ond band' (Amax z 310 nm) being of higher intensity 
than the lowest energy one, and its A, varying by 
- + 20 nm (not shown). 
Binding of 4aJ-Dihydro-FAD Models 
to Apo D-Amino Acid Oxidase 
and Properties of the Complexes 
Apo D-amino acid oxidase binds 4a-OH-FAD 
tightly. The process of binding is accompanied by the 
appearance of a fluorescence emission maximal at 
about 500 nm and by a marked change in the absorp- 
tion spectrum in the 360-400-nm region (Fig.2). 
4a-OH-FAD does not exhibit detectable fluorescence 
free in solution at room temperature. 
The spectrum of the resulting complex (Fig.2) is 
characterized by a single symmetric absorption band 
in the near ultraviolet with a maximum at 374 nm. The 
rate of binding, as monitored by the absorption and 
fluorescence changes (Fig. 3, upper part) is biphasic for 
the first 3 - 4 min. While the first phase is concentra- 
tion-dependent, the second slower phase is fairly well 
described as a first-order process with k = 1.43 min-'. 
This behavior is analogous to that found for the 
biphasic binding of normal FAD, as measured by 
fluorescence quenching, where the second reaction 
step has k = 0.7 min-l under similar conditions [25]. 
After the first two comparatively rapid phases, the 
absorption of the complex was found to undergo 
very small changes (Fig. 3, lower part), which were 
consistent with a species with a longer wavelength 
maximum changing to a final complex with Amax 
= 374nm. In contrast to this minor absorption 
change, the fluorescence emission decreases, after the 
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first rapid increase, to a quarter of its maximal value 
with t l p  z 15 min. During this process the excitation 
and emission spectra, which were recorded at constant 
Aexc .  = 382 nm, and Aemiss. = 498 nm, changed only 
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Fig. 3. Changes in fluorescence and absorbance upon binding of 4a- 
OH-FAD to apo D-amino acid oxidase. The figure represents a 
typical experiment in which the binding process was initiated by 
addition of concentrated solution of modified FAD (final con- 
centration 16 pM) to the apoprotein (20 pM) in 40 mM potassium 
phosphate buffer pH 7.55 at 25 "C. Curve (-----) represents the 
fluorescence changes occurring with time, excitation 382 nm, 
emission 495 nm, and curve (-) the absorbance changes 
recorded at 385 nm 
more, while the fluorescence excitation and emission 
spectra show temperature-dependent changes in their 
wavelength maxima (Table I), the absorption spectrum 
is largely unaffected. Corrected fluorescence excitation 
spectra (Table 1) do not coincide with the absorption 
spectra (Fig.2) showing a red shift of the excitation 
maximum. This suggests the presence of a single 
fluorescent species and that the dominant absorbing 
species is not identical with the fluorescent one. 
When a solution of apoenzyme is titrated with 
increments of 4a-OH-FAD no deviation from line- 
arity is evident in a plot of the observed spectral 
changes versus the amount of added FAD deriva- 
tive (Fig.4). Similarly a sharp titration plot is shown 
for the appearance of fluorescence (not shown) re- 
corded at the time of its maximal formation. Both 
fluorescence and absorption titrations indicate a 
Kd < l o - ?  M, and thus a better binding of 4a-OH- 
FAD as compared to normal FAD (Kd = 2.2 x lop7 M 
[37]). The end point of titrations such as in Fig.4 
corresponds to 1.09 equivalents of 4a-OH-FAD bound 
per apoenzyme flavin binding site; from this ~ 3 7 4  
z 9400 M-' cm-' can be estimated for the complex. 
That no chemical changes of 4a-OH-FAD occur 
upon binding to the protein is shown by the experiment 
outlined in Fig.2. Release of the modified coenzyme 
by acid denaturation of the protein leads to quantita- 
tive formation of the 5-ethyl-flavinium cation of FAD 
(Fig. 2). Based on the reasonable assumption that the 
~ 4 3 ~  and &550 values are constant for 5-ethyl-flavo- 
quinonium cations modified only in the N(10) side 
chain (lumiflavin or riboflavin derivatives) this experi- 
ment indicates an ~ 3 ~ 4  z 9500 M-' cm-l for the 
Table 1. Fluorescence properties of 4a,5-dihydro-flavins bound to apoflavoproteins 
The samples were prepared essentially as described in the legends of Fig. 2 and 5 
Complex Temperature Excitation i,,,, Emission I., 
flavin enzyme 
( ~ . e m L \ m , )  i ~ e r c l t B t l o n )  
T nm 
4a-OR-Lumiflavin [13] (free) - 
4a-OH-FAD D-amino acid oxidase 
4a,S-propano-FAD D-amino acid oxidase 
4a-OH-FAD p-hydroxybenzoate hydroxylase 
4a-OH-FAD + p-hydroxybenzoate p-hydroxybenzoate hydroxylase 
4a-OH-FAD + 5-aminonicotinate p-hydroxybenzoate hydroxylase 


































a Ghisla, S., Massey, V. & Hastings, W. (unpublished results). 
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Fig.4. Stoichiometry of binding of 4a-OH-FAD to upo u-amino 
acid oxidase. Freshly prepared apoenzyme 42 pM in 1.10 ml buffer 
pH 7.55 (5 mM sodium pyrophosphate, 35 mM potassium phos- 
phate) was titrated at 25 "C with increments of the modified FAD 
1.18 mM in 55 mM potassium acetate and 88 mM potassium phos- 
phate, pH 7.1. The absorbance changes at 385 nm were measured 
after complete equilibration of the system had occurred (zz 4 min) 
and are corrected for dilution 
protein-bound 4a-OH-FAD, in good agreement with 
the value obtained by direct titration. Neutralization 
of the acid solution of the modified FAD released 
from the protein restores the spectrum of 4a-OH-FAD. 
Hence the spectral changes resulting upon binding to 
apo-D-amino acid oxidase result from the specific 
interaction of the chromophore with the apoenzyme, 
and from protein conformational changes, but not 
from chemical modifications. It should be noted that 
the derivative is stabilized substantially on binding 
to D-amino acid oxidase; no significant decay of the 
protein-bound flavin was observed over 24 h at 0 "C. 
As expected from the altered chemical properties of 
the derivative no catalytic activity is observed with the 
modified enzyme. Apo D-amino acid oxidase similarly 
binds 4a-5-propano-4a,5-dihydro-FAD [38], and 
forms a fluorescent complex (Table 1). In this case, 
though, the spectral changes observed upon binding 
are comparatively small : the complex has an absorp- 
tion maximal at 382 nm ( E  6500 M-' cm-'), and 
a shoulder at 325nm, which compares to imax = 380nm 
( E  z 6500 M-' cm-') for the same FAD model, free 
in solution. 
Binding of 5-Ethyl-4a-hydroxy-4a,5-dihydro-FA D 
to Apo p-Hydroxybenzoate Hydroxylase 
and Properties of the Complex 
As in the case of D-amino acid oxidase, the apo- 
enzyme of p-hydroxybenzoate hydroxylase was found 
to bind 4a-OH-FAD tightly. Qualitative estimations 
indicate that one molecule of derivative is bound per 
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Fig. 5. Absorption spectra of 4a-OH-FAD bound to apo p-hydroxy- 
benzoate hydroxylase in the presence and absence of p-hydroxy- 
benzoate. 1.0 ml of 55 pM apoprotein solution was added to 
5 equiv. of 4a-OH-FAD to give a final solution of 1.4 ml of 80 mM 
potassium phosphate, 35 mM potassium acetate, 0.4 mM EDTA, 
and 0.25 mM p-hydroxybenzoate, pH 6.9 at 0 "C. The solution 
was incubated at 25 "C for 15 min and cooled to 0 "C. Excess de- 
rivative and p-hydroxybenzoate were removed by passage through 
Sephadex G-25 equilibrated with 0.05 M potassium phosphate 
buffer pH 7.5 containing 0.4 mM EDTA, at 4 "C.  Curve (-) 
represents the spectrum of the complex (22 pM) in the absence of 
p-hydroxybenzoate at 3 "C. Curve (-----) shows the same 
complex at 25 "C after addition ofp-hydroxybenzoate or of 6-amino- 
nicotinate to final concentrations of 0.85 mM and 0.62 mM re- 
spectively. The curve (0.. .  '0) represents the spectrum of inter- 
mediate I (peroxy adduct of reduced flavin). Reduced enzyme 
complex with p-hydroxybenzoate was reacted with oxygen in a 
stopped-flow spectrophotometer at 3.5 "C.  The final solution 
contained 17.7 pM enzyme, 0.5 mM p-hydroxybenzoate, 0.66 mM 
oxygen, 50 mM potassium phosphate, 25 mM EDTA (Na salt), 
pH 6.6. The open circles represent the experimentally measured 
absorbance of the solution at the wavelength, 20 ms after the end 
of flow. The dead time of the instrument was between 2 and 2.5 ms. 
Curve (- . ~ . -) represents the fluorescence excitation spectrum 
(arbitrary units on the vertical scales) of the p-hydroxy benzoate 
ternary complex recorded with Ae,,,iss. = 550 nm 
that for normal FAD. With this hydroxylase a detailed 
binding study was not possible due to the presence of 
inactive apoenzyme and the instability of the complex. 
The enzyme reconstituted with modified FAD had a 
small residual activity (z 1.5 %) attributable to the 
presence of residual FAD. The preparations of apo- 
enzyme used in this study showed consistently the 
presence of approximately 30 % inactive enzyme. Re- 
constitution with normal FAD indicates binding of 
one equivalent per apoenzyme unit, with an activity 
recovery of z 70 %. Similarly the apoprotein appears 
to bind one equivalent of 4a-OH-FAD. As in the 
case of D-amino acid oxidase, no catalytic activity was 
found. In the absence of the normal enzyme substrate, 
p-hydroxybenzoate, the complex has an absorption 
spectrum (Fig. 5) similar to those of 4a,5-dihydro- 
flavins in aqueous solution. p-Hydroxybenzoate is 
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bound to the complex with a Kd of 3 . 5 ~  M, 
estimated from absorbance changes, which compares 
to 3.2 x M for the binding to 'normal' oxidized 
holoenzyme [29], and also similar to that found for 
the reduced holoenzyme (2.1 x lop5  M) [l l] .  In the 
ternary complex the absorption of the lowest energy 
band appears red-shifted, and the shape of the 
spectrum is similar to that of the D-amino acid 
oxidase complex (Fig. 2), or to that of 4a,5-dihydro- 
flavins in apolar medium (Fig. 1). 6-Aminonicotinate 
(2-aminopyridine-5-carboxylic acid), a competitive 
inhibitor and effector of the enzyme, also binds very 
tightly, and causes an almost identical spectral shift. 
The absorption coefficient at 368 nm for these ternary 
complexes was estimated as approximately 8400 M-' 
cm-I by acid release of the modified FAD in an ex- 
periment similar to that described in Fig.2 for the 
apo D-amino acid oxidase complex. 
The complex of apoenzyme and 4a-OH-FAD 
exhibits fluorescence (x 30% that of native enzyme) 
with an excitation spectrum (Table 1) very similar 
to that of its absorption spectrum (Fig.5). In the 
ternary complex with the substratep-hydroxybenzoate 
the fluorescence excitation, when recorded at the 
emission maximum of 505 nm (Table l), and the 
absorption spectrum are similar and equally red- 
shifted (Fig. 5) .  However, when the excitation of this 
complex is recorded with Aemiss. = 460 and 550 nm, 
two different excitation spectra are obtained (Table 1, 
and Fig.5), clearly showing that two species with 
quantum yields of similar magnitude are present. 
These two curves probably do not represent the 
absolute spectra of each of the two possible forms, as 
some overlap of the corresponding emission spectra 
exists at 460 and 550nm. The absorption spectrum 
of the ternary complex (Amax = 368 nm, Fig.5) may 
be simulated reasonably well when the two spectral 
curves with A, z 382 and /I,,, = 357 nm, as obtained 
from the excitation spectra (Table 1, and Fig. 5), are 
taken in a ratio 2: 1. Thus the species with A,, 
M 382 nm, which best correlates the absorption of the 
transient oxygen intermediate (Fig. 5), most probably 
will constitute the main component in the complex. 
A similar, but clear-cut result is obtained from the 
ternary complex with the inhibitor 6-aminonicotinate. 
The fluorescence yield is now increased by about 
120 % relative to native enzyme and only one fluores- 
cent species is detectable. The emission maximum is 
blue-shifted to 470 nm (not shown). The excitation 
spectrum closely resembles the absorption spectrum 
of the binary complex of 4a-OH-FAD and apoenzyme 
(Fig. 5).  The noncoincidence of absorption and excita- 
tion spectra of the complex with 6-aminonicotinate 
indicate the presence of (at least) two species, one 
fluorescent and one nonfluorescent. 
These experiments also clearly demonstrate that 
substrate and inhibitor are bound by the two forms of 
complex between 4a-OH-FAD and p-hydroxybenzo- 
ate hydroxylase, and that in one form complexation 
does not lead to substantial spectral alterations of the 
complex. In contrast to this, with the other form a 
major spectral alteration occurs upon binding, and 
the occurrence of fluorescence depends on the chemical 
structure of the aromatic carboxylic acid bound. The 
very close similarity should be noted between the 
excitation spectrum of the complex with excitation 
maximum at 382 nm, and the spectrum of the flavin 
peroxide formed transiently when reduced native 
enzyme complexed with p-hydroxybenzoate reacts 
with oxygen (Fig. 5). Similar transient spectra have 
been reported earlier for a number of enzyme-substrate 
complexes [l l] .  
In contrast to the results obtained with D-amino 
acid oxidase, the 4a-OH-FAD bound to p-hydroxy- 
benzoate hydroxylase is markedly less stable; the 
characteristic absorbance at 370 nm decreases at 
pH 7.5, 25 "C, at a rate approximately one fifth that 
of the compound in free solution. 
One product of this process is enzyme-bound 
neutral radical as indicated by the absorption at about 
500 nm, and by the fact that the normal spectrum of 
the enzyme derivative can be restored partially by 
oxidation with ferricyanide. Further products prob- 
ably represent compounds in which the pyrimidine 
moyety of the isoalloxazine has been hydrolyzed 
(Ghisla, S., unpublished). 
Rap id React ion 
of Reduced p-Hydroxybenzoate Hydroxylase - 
6-Hydroxynicotinate Complex with Oxygen; 
Search j o r  Fluorescence from a Transient Intermediate 
The finding of a fluorescence emission from 4a- 
OH-FAD bound to apohydroxybenzoate hydroxylase 
suggested a further experimental approach to verify 
the chemical constitution of the observed intermediates 
[l]. The enzyme effector 6-hydroxynicotinate was 
selected, because in this case only one oxygen inter- 
mediate with an absorbance maximal at 383 nm had 
been observed [ll].  At 388 nm the observed oxygenat- 
ed intermediate and oxidized enzyme have an isos- 
bestic point; thus at this wavelength only the formation 
of the intermediate from reduced enzyme will be de- 
tected (k  = 30 s-l with 0.13 mM oxygen, Fig.6). At 
460 nm the intermediate has the same absorbance as 
reduced enzyme, so the change will represent forma- 
tion of oxidized enzyme only (final rate = 10.6 s-l). 
The time course of the fluorescence excitation changes 
observed at 380 nm and 460 nm for reaction of the 
reduced complex with O2 parallel the absorbance 
changes at 460nm due to formation of oxidized 
enzyme (Fig. 6), indicating that the intermediate (57 % 
formed at the maximum under these conditions) has 
no detectable fluorescence compared to that of oxidiz- 
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and thus more detailed binding studies could not be 
carried out. 
Y I I I I 
100 200 300 400 
Time (rns) 
Fig. 6. Comparison o j  absorption and fluorescence emission changes 
occurring during the reaction of reduced p-hydroxyhenzoate hydroxy- 
lase complexed with the effector 6-hydroxynicotinate with oxygen. 
The time course of absorbance changes were recorded with a 
stopped-flow instrument at the wavelengths indicated at 5 'C, and 
the fluorescence emission changes with excitation at the indicated 
wavelengths at 1.5 ~ 2.0 "C. For fluorescence measurements, when 
the excitation wavelength was 460 nm a filter (Corning CS-370) 
which transmits light only at wavelength > 500nm was placed 
between the reaction cell and the photodetector. For 380-nm 
excitation either this filter or one (Corning CS-373) which transmits 
at wavelengths greater than 410 nm was used. The final reaction 
solution contained 17.6 pM enzyme, 10 mM nicotinate, 0.13 mM 
oxygen, 20 nm EDTA, and 50 mM potassium phosphate, pH 6.55. 
The time course of fluorescence changes was identical with either 
filter 
ed enzyme. If the intermediate had fluorescence greater 
than 10 % that of oxidized enzyme the time course of 
fluorescence change should have been observedly 
faster with 380-nm excitation than with 460-nm 
excitation, and should have depended on the wave- 
length range of fluorescence emission which was 
monitored. 
Binding of 5-Ethyl-4a-hydroxy-4a,5-dihydro- FMN 
to Apo Lactate OxidaJe 
The behavior of 4a-OH-FMN with apo lactate 
oxidase is comparable to that found, with the two 
previously described enzymes. One derivative equi- 
valent is bound per apoprotein molecule, and the 
complex resulting has an absorption spectrum with 
maxima at 320 and 375 nm, and a fluorescence emis- 
sion which is considerably red-shifted compared to 
that of the other apo enzyme complexes (Table 1). The 
excitation spectrum does not correspond to the ab- 
sorption spectrum in that its maximum is shifted to 
400 nm, again indicating the presence of two chromo- 
phores. As judged from the decrease of the absorption 
spectrum occurring in the 350 - 400-nm region over 
a period of a few hours, the complex was not stable, 
Binding Behavior of 5-Ethyl-4a-hydroxy Derivatives 
of FAD and FMN to Other Apoflavoproteins 
The binding studies detailed above were qualita- 
tively extended to a series of apoflavoproteins avail- 
able to us. Within the flavodoxins, the apoprotein 
from Anacystis nidulans did not bind 4a-OH-FMN or 
its reduced form, 5-ethyl-l,5-dihydro-FMN. Upon 
incubation of 4a-OH-FMN with the apoenzyme of 
Peptostreptococcus elsdenii, the formation of a blue 
colour was observed, and the absorption spectrum of 
a Sephadex G-25 protein eluate indicated the presence 
of a protein-bound mixture of 5-ethyl-FMN radical 
and 5-ethyl-l$dihydro-FMN. After 15 min at 25 "C 
the mixture had converted quantitatively to protein- 
bound 5-ethyl-FMN radical. Further, much slower 
changes followed, as shown by the disappearance of 
the radical spectrum; they did not lead to the 4a-OH- 
FMN derivative spectrum, but to yet unidentified 
species; these are probably similar to the decay 
products of 4a-OH,5-R-isoalloxazines, which will be 
described elsewhere (Ghisla, S. ,  unpublished results). 
The apoenzyme of phenol hydroxylase and melilotate 
hydroxylase yielded upon incubation with 4a-OH- 
FAD considerable amounts of blue radical, which was 
not bound to a detectable extent by the apoprotein, 
i. e. did not cochromatograph with the protein fraction 
on Sephadex G-25. 
DISCUSSION 
Spectra of transient flavin peroxide have been 
reported for four enzymes, p-hydroxybenzoate hydro- 
xylase [ll],  melilotate hydroxylase [8], phenol hydro- 
xylase [2] and bacterial luciferase [39]. Within this 
group the flavin peroxide varies in wavelength maxi- 
mum from 370 to 395 nm, and in absorption coefficient 
from 8000 to 10000 cm-'. In all these cases the inter- 
mediate, being short-lived, has precluded characteriza- 
tion by chemical trapping or by other spectroscopic 
methods. Hence, structural elucidation has to rely 
on comparison of the spectral properties with those of 
known flavin derivatives. On the basis of such com- 
parison it has been suggested that in all cases the 
oxygenated intermediate is a C (4a)-flavin peroxide. 
This assignment is not unambiguous, however, since 
considerable spectral variation is found in C (4a)- 
substituted dihydroflavins, depending on the nature 
of the substituents and on the solvent (Fig. 1). In the 
case of p-hydroxybenzoate hydroxylase, the sequential 
occurrence of three oxygen-containing intermediates 
[ll] has been shown. Two of these, intermediates I 
and 111, have almost identical spectra which were 
attributed to the 4a-00H and 4a-OH adducts re- 
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spectively. Therefore it must be concluded that with 
the enzyme intermediates, in contrast to the free 
system (Fig.l), the main effect on the spectral pro- 
perties of the substituted flavin comes from the en- 
vironment imposed by the protein structure. Hence 
evidence obtained from binding studies to apoproteins 
with C(4a)-hydroxy flavins at the FMN and FAD 
level should be satisfactory for deductions basing on 
spectral properties of the enzyme intermediates. 4a- 
OH-FAD bound to apo D-amino acid oxidase and 
apo p-hydroxybenzoate hydroxylase indeed was found 
to yield complexes with spectra closely similar, in all 
respects to those of the catalytic oxygen adducts 
(Fig.2 and 5). While keeping in mind the restrictions 
inherent to the system and the experimental limitations 
outlined above, we consider that the results presented 
here clearly support the C(4a)-OOH and C(4a)-OH 
structure for the intermediates in question. 
This type of intermediate might well occur during 
the process of oxygen activation with the flavoprotein 
oxidases, where the corresponding intermediates could 
have escaped detection for kinetic reasons. 
The noncoincidence of the fluorescence excitation 
and absorption spectra indicate that two species are 
present in the complex between 4a-OH-FAD and 
apo D-amino acid oxidase. It is improbable that these 
two forms represent 4a-OH-FAD complexes with 
apoenzyme of different activity, since the same pre- 
parations of apoenzyme could usually be reconverted 
to fully active enzyme with normal FAD. The linearity 
of the titration curves and the stoichiometry of bind- 
ing, which was found to be close to unity, suggest 
that a single molecular type is bound. On the other 
hand, 4a-OH-FAD can be represented in the two 
following enantiomeric forms, which can interconvert 
in solution (over its symmetric flavin cation) and 
could both bind with similar Kd values to the apo- 
enzyme, giving rise to different properties of each 
form in the asymmetric enzyme matrix : 
and apo D-amino acid oxidase might represent slow 
equilibration of the two enantiomers, after preferen- 
tial binding of one, either in the enzyme complex, or 
upon slow dissociation from the complex. A similar 
interpretation would also account for the finding of 
at least two 4a-OH-FMN complexes with apo lactate 
oxidase. With p-hydroxybenzoate hydroxylase the 
experimental results are compatible with the presence 
of two types of complexes: 4a-OH-FAD bound to 
active ( FZ 70 %) and inactive enzyme ( % 30 %). Theo- 
retically, however, the possible combinations would 
be four, the two enantiomers of 4a-OH-FAD bound 
to active and inactive enzyme. In this case one enan- 
tiomer may bind preferentially, as in the case of apo- 
flavodoxin [40], or less probably, the enzyme-bound 
enantiomers could have similar spectral properties. 
The variation in light absorption and fluorescence 
properties of the complexes is not surprising in view 
of the variety of factors affecting the properties of 
4a,5-dihydroflavin models (Fig. 1). Thus the drastic 
effect on the fluorescence found upon binding of the 
effector 6-aminonicotinate can be interpreted as en- 
hancement of the fluorescence of the inactive enzyme 
complex and quenching of the active enzyme complex 
with 4a-OH-FAD. Similarly, the lack of detectable 
fluorescence in the catalytic oxygen intermediate as 
compared to the ternary complex of 4a-OH-FAD, 
enzyme and substrate might originate in small differ- 
ences in the coenzyme-protein interactions. For ex- 
ample, specific hydrogen bridges to position N ( 5 )  of 
the reduced flavin might not be possible in N(5)- 
substituted coenzyme complexes ; such bridges are 
likely to constitute a major factor in fluorescence 
quenching. In fact N (5)-substituted 1,5-dihydroflavins 
have a much higher fluorescence yield as compared to 
unsubstituted models at low temperature in rigid 
medium [13], and a very strong increase in fluorescence 
intensity has been observed upon N (5)-substitution 
of reduced lactate oxidase FMN [13]. 
Support for this concept comes from the recent 
finding that the two stable enantiomers of 4a-propyl- 
4a,5-dihydro-FMN can be resolved and shown to 
bind to apoflavodoxin rather weakly, though with K d  
differences larger than 100-fold [40]. 
The slow secondary fluorescence changes occurring 
after formation of the complex between 4a-OH-FAD 
The conclusions which can be drawn from the 
present studies apply for the intermediates of types I 
and I11 [ll],  observed within the hydroxylases [2,8, 
111, and to the bacterial luciferase oxygen adduct [39]; 
clearly they do not support, in our opinion, the 
proposal by Muller et al. [17] that these intermediates 
are 9a-flavin adducts. As binding of flavin chromo- 
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phores to apoflavoproteins in general causes batho- 
chromic shifts of absorption I,,, and fluorescence 
emission Amax (Fig. 2, 5, and Table 1 [42,43]), Muller’s 
models, which in solution already have the lowest 
energy transitions at A > 400 nm (absorption I,,, 
= 372-460 nm, fluorescence emission A, = 530- 
572 nm [17,41]), would show A, shifted still further 
to the red upon binding to apoproteins. 
The present work neither supports nor disproves 
the interesting hypothesis put forward by Hemmerich 
[4,44] that the high-absorption intermediate I1 of the 
p-hydroxybenzoate hydroxylase reaction has a 1,9a- 
dihydro structure. A discussion of this possibility and 
its mechanistic relevance and implications will be 
found elsewhere [4,11,44]. 
with Prof. P. Hemmerich in the course of this work. 
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